Latvia - Lipid Modifying Medicine Use
Since 2014, Latvia Lipid Modifying Medicine Use grew 10.5% year on year. With 92.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 24 among other countries in Lipid Modifying Medicine Use. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% versus 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania recorded the best 5 years average growth at +18.8% per year, while Slovakia was the worst growing country at -8.7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 92.80 |
| 2018 | 84.50 |
| 2017 | 79.40 |
| 2016 | 67.80 |
| 2015 | 62.50 |
Download all data from 2012 to 2019
How does Latvia rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 22 |
#22
Germany
|
94 | 2019 | +2.7 % | +4.3 % | View data | |
| 24 |
#24
Latvia
|
93 | 2019 | +9.8 % | +10.5 % | View data | |
| 25 |
#25
South Korea
|
74 | 2019 | +2.4 % | +7.3 % | View data | |